Cellular Mucins: Targets for Immunotherapy

Critical Reviews in Immunology
V Apostolopoulos, Ian F C McKenzie

Abstract

Mucins are attracting great interest as potential targets for immunotherapy in the development of vaccines for cancers expressing Mucinl (MUC1) (e.g., breast, pancreas, ovary, and others) as there is (1) a 10-fold increase in the amount in adenocarcinomas; (2) an alteration in expression where they become ubiquitous, and (3) due to altered glycosylation, new epitopes appear on the cell surface that are absent in normal tissues. These new epitopes can be carbohydrate; others are peptide in nature. The cloning of the cDNAs from mucins, particularly MUC1, has led to rapid advances being made, and it is clear that a highly immunogenic peptide exists within the variable number of tandem repeats (VNTR) found in all mucins. This peptide is immunogenic in mice, giving rise to strong antibody production, and most monoclonal antibodies made to breast cancer, which react with the protein core, react with the peptide APDTR. It is now also clear that humans with breast cancer have, in their draining lymph nodes, precursors of cytotoxic T cells that can be stimulated in vitro to react against breast cancer and indeed against the APDTR or a closely related peptide - shown from antibody-blocking studies. These CTLs are unique in that they are ...Continue Reading

Citations

Mar 13, 2019·Nature Reviews. Nephrology·Colin ReilyJan Novak
Mar 12, 2021·Glycoconjugate Journal·Inka Brockhausen, Jacob Melamed
Apr 17, 2021·Biochimica Et Biophysica Acta. Reviews on Cancer·Nicolas JonckheereIsabelle Van Seuningen
May 5, 2021·Cancer Immunology, Immunotherapy : CII·Edgardo BerrielEduardo Osinaga

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Related Papers

Critical Reviews in Immunology
V Apostolopoulos, I F McKenzie
Current Opinion in Molecular Therapeutics
V ApostolopoulosI F McKenzie
Biochimica Et Biophysica Acta
J Taylor-PapadimitriouM Dalziel
© 2022 Meta ULC. All rights reserved